Marks & Clerk accused over ‘secret commissions’ from IP referrals

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Marks & Clerk accused over ‘secret commissions’ from IP referrals

c0a6c8dd-7096-4a29-82d8-63ce4a28fe8bhigh-court-mw-600-comp.jpg

The IP firm faces a group-action claim that it profited from external renewals work without clients’ knowledge

An organisation representing mainly SMEs has filed a group-action lawsuit against Marks & Clerk alleging that the firm received “secret commissions” for referring intellectual property renewals work.

The particulars of claim was filed at the England and Wales High Court on Monday, April 12, by an organisation called Commission Recovery Limited (CRL). The allegations concern work that M&C referred to IP services provider CPA Global, which is not listed as a defendant.

The claim alleges that while clients agreed to CPA Global taking on their renewals work, they were unaware of the commissions being paid to M&C, and that these payments constituted unauthorised profit.

According to a CRL statement, these secret commissions have earned M&C between £2 million ($2.7 million) and £3 million per year in the UK – with the total figure likely to exceed £50 million.

A spokesperson for M&C told Managing IP that the firm categorically denies any wrongdoing.

“The claimant, CRL, and its founder are commercially driven and motivated by their own business interests. The allegations mischaracterise the work we undertake and our relationship with CPA. We will defend the claim vigorously.”

Peter Rouse, founder of CRL, said: “It is simply unacceptable that a firm like Marks & Clerk would develop a secret commissions scheme solely designed to line their own pockets while exploiting the very businesses they claim to serve.”

He added: “We want to provide a mechanism for affected businesses – who have been taken advantage of for years – to seek the justice and compensation they deserve.”

A spokesperson for Clarivate, which acquired CPA Global in 2020, said it “categorically and emphatically” denies any wrongdoing, adding: “Neither Clarivate nor CPA Global are named as defendants in the legal action.”

The claim has been brought as a representative action on behalf of all current and former clients of M&C and its predecessor practices. Unlike some group-action claims where parties can choose to join, this is an opt-out claim. Potentially affected claimants do not need to join or sign up.

The claim comes five years after CPA Global itself was sued for allegedly overcharging for foreign patent renewal fees. The 2016 class-action lawsuit was filed in the US by medical diagnostic company Run Them Sweet. That case was later settled.

 

more from across site and SHARED ros bottom lb

More from across our site

AG Barr acquires drinks makers Fentimans and Frobishers, in deals worth more than £50m in total
Tarun Khurana at Khurana & Khurana says corporates must take the lead if patent filing activity is to truly translate into innovation
Michael Moore, head of legal at Glean AI, discusses how in-house IP teams can use AI while protecting enforceability
Counsel for SEP owners and implementers are keeping an eye on the case, which could help shape patent enforcement strategy for years to come
Jacob Schroeder explains how he and his team secured victory for Promptu in a long-running patent infringement battle with Comcast
After Matthew McConaughey registered trademarks to protect his voice and likeness against AI use, lawyers at Skadden explore the options available for celebrities keen to protect their image
The Via members, represented by Licks Attorneys, target the Chinese company and three local outfits, adding to Brazil’s emergence as a key SEP litigation venue
The firm, which has revealed profits of £990,837, claims it is the disruptive force in the IP-legal industry
In the first of a two-parter, lawyers at Santarelli analyse the patentability of therapeutic inventions where publication of clinical trial protocols occurs before the application's filing date
Arun Hill at Clarivate assesses the Top 100 Global Innovators 2026 list, including why AI has assumed a strategic importance for innovation
Gift this article